Canada markets closed

Oragenics, Inc. (OGEN)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.0600-0.0300 (-2.75%)
At close: 03:53PM EDT
1.1100 +0.05 (+4.72%)
After hours: 06:50PM EDT

Oragenics, Inc.

4902 Eisenhower Boulevard
Suite 125
Tampa, FL 33634
United States
813 286 7900
https://www.oragenics.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 5

Key Executives

NameTitlePayExercisedYear Born
Mr. Charles L. Pope CPAExecutive Chairman112.5kN/A1952
Mr. Joseph Michael RedmondPresident & Interim Principal Executive OfficerN/AN/A1961
Ms. Janet HuffmanCFO, Secretary & Treasurer314.9kN/A1972
Dr. James P. Kelly M.A., M.D.Chief Medical Officer & Member of Scientific AdvisorN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Oragenics, Inc., a development-stage company, engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

Corporate Governance

Oragenics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.